Cargando…
Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital
INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107418/ https://www.ncbi.nlm.nih.gov/pubmed/33970428 http://dx.doi.org/10.1007/s11739-021-02750-8 |
_version_ | 1783689946103545856 |
---|---|
author | Carnicelli, Annamaria Fiori, Barbara Ricci, Rosalba Piano, Alfonso Bonadia, Nicola Taddei, Eleonora Fantoni, Massimo Murri, Rita Cingolani, Antonella Barillaro, Christian Cutuli, Salvatore Lucio Marchesini, Debora Della Polla, Davide Antonio Forte, Evelina Fuorlo, Mariella Di Maurizio, Luca Amorini, Paola Cattani, Paola Franceschi, Francesco Sanguinetti, Maurizio |
author_facet | Carnicelli, Annamaria Fiori, Barbara Ricci, Rosalba Piano, Alfonso Bonadia, Nicola Taddei, Eleonora Fantoni, Massimo Murri, Rita Cingolani, Antonella Barillaro, Christian Cutuli, Salvatore Lucio Marchesini, Debora Della Polla, Davide Antonio Forte, Evelina Fuorlo, Mariella Di Maurizio, Luca Amorini, Paola Cattani, Paola Franceschi, Francesco Sanguinetti, Maurizio |
author_sort | Carnicelli, Annamaria |
collection | PubMed |
description | INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with a worse prognosis. METHODS: We performed a cross-sectional analysis to determine the presence and the levels of both anti-SARS-CoV-2 IgG and IgA in a cohort of hospitalized patients with confirmed infection at different times in the natural history of the disease. Patients enrolled when admitted at the emergency department were prospectively followed up during hospital stay. RESULTS: Overall, 131 patients were considered with a total of 237 samples processed. Cross-sectional analysis showed that seroconversion for IgA seems to occur between days 6 and 15, while IgG response seems to occur slightly later, peaking at day 20 after symptoms onset. Both IgA and IgG were maintained beyond 2 months. Severe patients showed a higher IgA response compared with mild patients when analyzing optical density (8.3 versus 5.6, p < 0.001). Prospective analysis conducted on 55 patients confirmed that IgA appear slightly earlier than IgG. After stratifying for the severity of disease, both the IgA and IgG responses were more vigorous in severe cases. Moreover, while IgG tended to stabilize, there was a relevant decline after the first month of IgA levels in mild cases. CONCLUSION: IgA and IgG antibody response is closely related, although seroconversion for IgA occurs earlier. Both IgA and IgG are maintained beyond 2 months. Severe patients showed a more vigorous IgA and IgG response. IgA levels seem to decline after 1 month since the onset of symptoms in mild cases. Our results should be interpreted with cautions due to several limitations in our study, mainly the small number of cases, lack of data on viral load and clinical setting. |
format | Online Article Text |
id | pubmed-8107418 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-81074182021-05-10 Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital Carnicelli, Annamaria Fiori, Barbara Ricci, Rosalba Piano, Alfonso Bonadia, Nicola Taddei, Eleonora Fantoni, Massimo Murri, Rita Cingolani, Antonella Barillaro, Christian Cutuli, Salvatore Lucio Marchesini, Debora Della Polla, Davide Antonio Forte, Evelina Fuorlo, Mariella Di Maurizio, Luca Amorini, Paola Cattani, Paola Franceschi, Francesco Sanguinetti, Maurizio Intern Emerg Med Im - Original INTRODUCTION: Antibody response plays a fundamental role in the natural history of infectious disease. A better understanding of the immune response in patients with SARS-CoV-2 infection could be important for identifying patients at greater risk of developing a more severe form of disease and with a worse prognosis. METHODS: We performed a cross-sectional analysis to determine the presence and the levels of both anti-SARS-CoV-2 IgG and IgA in a cohort of hospitalized patients with confirmed infection at different times in the natural history of the disease. Patients enrolled when admitted at the emergency department were prospectively followed up during hospital stay. RESULTS: Overall, 131 patients were considered with a total of 237 samples processed. Cross-sectional analysis showed that seroconversion for IgA seems to occur between days 6 and 15, while IgG response seems to occur slightly later, peaking at day 20 after symptoms onset. Both IgA and IgG were maintained beyond 2 months. Severe patients showed a higher IgA response compared with mild patients when analyzing optical density (8.3 versus 5.6, p < 0.001). Prospective analysis conducted on 55 patients confirmed that IgA appear slightly earlier than IgG. After stratifying for the severity of disease, both the IgA and IgG responses were more vigorous in severe cases. Moreover, while IgG tended to stabilize, there was a relevant decline after the first month of IgA levels in mild cases. CONCLUSION: IgA and IgG antibody response is closely related, although seroconversion for IgA occurs earlier. Both IgA and IgG are maintained beyond 2 months. Severe patients showed a more vigorous IgA and IgG response. IgA levels seem to decline after 1 month since the onset of symptoms in mild cases. Our results should be interpreted with cautions due to several limitations in our study, mainly the small number of cases, lack of data on viral load and clinical setting. Springer International Publishing 2021-05-10 2022 /pmc/articles/PMC8107418/ /pubmed/33970428 http://dx.doi.org/10.1007/s11739-021-02750-8 Text en © Società Italiana di Medicina Interna (SIMI) 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Im - Original Carnicelli, Annamaria Fiori, Barbara Ricci, Rosalba Piano, Alfonso Bonadia, Nicola Taddei, Eleonora Fantoni, Massimo Murri, Rita Cingolani, Antonella Barillaro, Christian Cutuli, Salvatore Lucio Marchesini, Debora Della Polla, Davide Antonio Forte, Evelina Fuorlo, Mariella Di Maurizio, Luca Amorini, Paola Cattani, Paola Franceschi, Francesco Sanguinetti, Maurizio Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title | Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title_full | Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title_fullStr | Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title_full_unstemmed | Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title_short | Characteristic of IgA and IgG antibody response to SARS-CoV-2 infection in an Italian referral COVID-19 Hospital |
title_sort | characteristic of iga and igg antibody response to sars-cov-2 infection in an italian referral covid-19 hospital |
topic | Im - Original |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107418/ https://www.ncbi.nlm.nih.gov/pubmed/33970428 http://dx.doi.org/10.1007/s11739-021-02750-8 |
work_keys_str_mv | AT carnicelliannamaria characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT fioribarbara characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT riccirosalba characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT pianoalfonso characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT bonadianicola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT taddeieleonora characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT fantonimassimo characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT murririta characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT cingolaniantonella characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT barillarochristian characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT cutulisalvatorelucio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT marchesinidebora characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT dellapolladavideantonio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT forteevelina characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT fuorlomariella characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT dimaurizioluca characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT amorinipaola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT cattanipaola characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT franceschifrancesco characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital AT sanguinettimaurizio characteristicofigaandiggantibodyresponsetosarscov2infectioninanitalianreferralcovid19hospital |